Gapping down
In reaction to disappointing earnings/guidance:
- JELD -13.3% (lowers Q3 adj EBITDA guidance with downside sales guidance; also announces promotion of John Linker to CFO, effective November 8), DPZ -5.6%, BLK -3.5%, PANW -1.8% (names Amit Singh as president effective Nov 1; reaffirms Q1 guidance for EPS of $1.04-1.06 vs. $1.06 S&P Capital IQ Consensus and revs of $625 -635 mln vs. $632.46 mln consensus), JNJ -0.5%
Other news:
- IGC -16.5% (files for $100 mln mixed securities shelf offering)
- CRMD -11% (files for approx 15 mln share common stock offering by selling stockholders issuable upon the exercise of warrants)
- TWLO -3.3% (Twilio to acquire SendGrid in an all-stock transaction valued at approximately $2 billion)
- ACRS -2.3% (Aclaris Therapeutics to acquire worldwide rights to RHOFADE from Allergan Sales; purchase price includes upfront cash payment of $65 mln), .
Analyst comments:
- AMRX -1.8% (downgraded to Hold from Buy at SunTrust)
- PF -0.4% (downgraded to Hold from Buy at Jefferies)
![]()